GLPwatch
Papers (12034)
Page 88 of 201, ranked by citation count.
- In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation.
- Determining whether the effect of liraglutide on non-alcoholic fatty liver disease depends on reductions in the body mass index.
- Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo-controlled trial.
- Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Spanish Setting.
- The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity.
- Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults: Risks beyond muscle mass reductions.
- Exendin-4 increases absence-like seizures and anxiety-depression-like behaviors in WAG/Rij rats.
- New Glucose-Lowering Agents for Diabetic Kidney Disease.
- The design of the liraglutide clinical trial programme.
- Exenatide improves glucocorticoid-induced glucose intolerance in mice.
- Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment.
- Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists.
- The cost-effectiveness of dulaglutide versus insulin glargine for the treatment of type 2 diabetes mellitus in Japan.
- Leptin restores the insulinotropic effect of exenatide in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and high-fat diet.
- Tirzepatide-Induced Injection Site Reaction.
- Euglycemic Ketoacidosis in a Non-diabetic Patient After Tirzepatide Use: A Cautionary Tale.
- Exenatide exerts a neuroprotective effect against diabetic cognitive impairment in rats by inhibiting apoptosis: Role of the JNK/c‑JUN signaling pathway.
- Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program.
- Semaglutide in Psychiatry-Opportunities and Challenges.
- Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.
- Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus.
- Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk.
- Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism.
- Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.
- Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonists.
- Liraglutide and Renal Outcomes in Type 2 Diabetes.
- Effects of Treatment with Liraglutide Early after Surgical Intervention on Clinical Outcomes in Patients with Short Bowel Syndrome: A Pilot Observational "Real-Life" Study.
- Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study.
- Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial.
- Exploring Hypoglycemic Ketoacidosis in Nondiabetic Patients on Tirzepatide: Is Starvation the Culprit?
- Subcutaneous adipose tissue composition and function are unaffected by liraglutide-induced weight loss in adults with type 1 diabetes.
- IDegLira fixed-ratio combination in the real world: a retrospective observational single-center Italian experience.
- Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis.
- Lithocholic Acid-Based Peptide Delivery System for an Enhanced Pharmacological and Pharmacokinetic Profile of Xenopus GLP-1 Analogs.
- Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach.
- Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
- Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow?
- Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells.
- Dysregulation of DPP4 Is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes Under Insulin Resistance Status and Liraglutide Intervention.
- Exenatide reduces atrial fibrillation susceptibility by inhibiting hKv1.5 and hNav1.5 channels.
- Sgemaglutide in type 2 diabetes - is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?
- Semaglutide for Weight Loss: Was It Worth the Weight?
- An Investigative Study of Pancreatic Exocrine Biomarkers, Histology, and Histomorphometry in Male Zucker Diabetic Fatty (ZDF) Rats Given Dulaglutide by Subcutaneous Injection Twice Weekly for 13 Weeks.
- Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort study.
- In vitro comparison of various antioxidants and flavonoids from Rooibos as beta cell protectants against lipotoxicity and oxidative stress-induced cell death.
- Semaglutide for adults living with obesity.
- Storage and Utilization of Glycogen by Mouse Liver during Adaptation to Nutritional Changes Are GLP-1 and PASK Dependent.
- Cost-effectiveness of second-line empagliflozin versus liraglutide for type 2 diabetes in the United States.
- Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin.
- Liraglutide-induced Acute Gastroparesis.
- Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis.
- A case of recalcitrant hidradenitis suppurativa concomitantly treated with tirzepatide.
- Efficacy and safety of GLP-1 agonists in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.
- The investigation of therapeutic potential of oxytocin and liraglutide on vincristine-induced neuropathy in rats.
- Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice.
- Intelligent Escape System for the Oral Delivery of Liraglutide: A Perfect Match for Gastrointestinal Barriers.
- Comparing the Efficacy and Safety of Obeticholic Acid and Semaglutide in Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review.
- Risk of Hypoglycemia After Concomitant Use of Antidiabetic, Antihypertensive, and Antihyperlipidemic Medications: A Database Study.
- Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India.
- Treatment of obesity with medications binding the glucagon-like peptide 1 receptor: what is the current state of play?